Relationship Between Plasma Iohexol Clearance and Urinary Exogenous Creatinine Clearance in Dogs
Overview
Veterinary Medicine
Authors
Affiliations
The objective of this study was to determine if plasma iohexol clearance, computed by a 1-compartment model defined by 3 plasma samples. was an accurate measure of glomerular filtration rate (GFR) in dogs. Twenty-two adult Beagle dogs of both genders were studied. Ten dogs had intact kidneys, and 12 dogs had surgically reduced renal mass. A bolus injection of iohexol was made, and blood was obtained for plasma iohexol assay after 120, 180, and 240 minutes. Plasma was analyzed for iohexol concentration by means of 3 assay methods: chemical, high-performance liquid chromatography (HPLC), and inductively coupled plasma emission spectroscopy (ICP). Urinary clearance of exogenous creatinine was used to measure GFR for three 30-minute periods occurring between 150 and 240 minutes after iohexol injection. Plasma clearance of iohexol and renal clearance of creatinine were compared by linear regression analysis and by limits of agreement techniques. Plasma iohexol clearance and urinary exogenous creatinine clearance were significantly correlated (chemical R2 = .90; HPLC R2 = .96; and ICP R2 = .96). The 1-compartment iohexol clearance:exogenous creatinine clearance ratios were 1.04 +/- 0.17, 1.05 +/- 0.14, and 1.10 +/- 0.15 for the chemical, HPLC, and ICP methods of assay, respectively, indicating that plasma iohexol clearance slightly overestimated GFR. Assuming a +/- 2 standard deviation interval for error, corrected plasma iohexol clearance measured GFR with +/-34% accuracy for the chemical, +/-26% accuracy for the HPLC, and +/-27% accuracy for the ICP method. These results indicate that plasma iohexol clearance should have utility for detection of renal dysfunction earlier in the course of progressive renal disease than is possible with measurement of plasma creatinine or urea concentrations.
Evaluation of renal function in dogs using pulsed Doppler ultrasonography.
Ito T, Hanazono K, Miyoshi K, Endoh D Open Vet J. 2025; 14(12):3449-3459.
PMID: 39927338 PMC: 11799656. DOI: 10.5455/OVJ.2024.v14.i12.29.
Reisinger A, Stubing H, Ishii P, Suchodolski J, Lidbury J, Busch K Animals (Basel). 2024; 14(6).
PMID: 38540064 PMC: 10967324. DOI: 10.3390/ani14060963.
Kaplan J, Visser L, Gunther-Harrington C, Ontiveros E, Wittenburg L, Palm C J Vet Intern Med. 2022; 36(6):1892-1899.
PMID: 36098206 PMC: 9708424. DOI: 10.1111/jvim.16537.
Baklouti S, Concordet D, Borromeo V, Pocar P, Scarpa P, Cagnardi P Front Pharmacol. 2021; 12:634404.
PMID: 33995036 PMC: 8116701. DOI: 10.3389/fphar.2021.634404.
Dhondt L, Croubels S, De Paepe P, Goethals K, De Cock P, Devreese M Front Pharmacol. 2021; 11:607101.
PMID: 33574754 PMC: 7870502. DOI: 10.3389/fphar.2020.607101.